Skip to content

Mobile Technology and Data Analytics to Identify Real-time Predictors of Caregiver Well-Being

Mobile Technology and Data Analytics to Identify Real-time Predictors of Caregiver Well-Being

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04556591
Enrollment
72
Registered
2020-09-21
Start date
2020-11-05
Completion date
2021-06-07
Last updated
2023-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregivers

Keywords

Depression, Insomnia, Stress related disorders, Anxiety

Brief summary

The purpose of this study is to test whether personalized messages from an easy-to-use mobile app improve mood and stress among care partners and to see if care partners like using the app.

Interventions

JITAI is an emerging intervention that incorporates passive mobile sensor data feedback (sleep and activity \[step\] data from a Fitbit ®), and real-time self-reporting of HRQOL via a study specific app called CareQOL to provide personalized feedback via app alert.

BEHAVIORALControl

Participants will wear the Fitbit® and provide daily reports of HRQOL over a three-month (90 day) period

Sponsors

National Center for Advancing Translational Sciences (NCATS)
CollaboratorNIH
University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

This behavioral trial will use a two-arm randomized controlled design.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Care Partner Inclusion Criteria: * Provide emotional, physical, and/or financial support/assistance to an individual with spinal cord injury (SCI), Huntington's Disease (HD), or hematopoietic cell transplantation (HCT) * Have access to necessary resources for participating in a technology-based intervention (smartphone/tablet and internet access) and be willing to use their personal equipment/internet for this study, including downloading the study app and the Fitbit® app on their mobile device * Care partners of persons with HD: Be caring for an adult (18 years or older) with a clinical diagnosis of HD * Care partners of persons with SCI: Be caring for an adult (18 years or older) that is ≥1 post-injury and sustained a medically documented SCI at age 16 or older * Care partners of persons with HCT: Be caring for an adult (18 years or older) who is receiving, has received or is scheduled to receive HCT

Exclusion criteria

* Is a professional, paid caregiver (e.g., home health aide)

Design outcomes

Primary

MeasureTime frameDescription
Feasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility Questionnaire3 months of wearing the Fitbit and completing the surveysItems are scaled from 1 to 5 to indicate the level of agreement, where 1 indicates strong disagreement and 5 indicates strong agreement. Percentages shown are the combined percentage of participants who selected agree or strongly agree or their equivalent (as labeled).

Secondary

MeasureTime frameDescription
Attrition as Measured by the Percent of Participants Completing the Study3 months of wearing the Fitbit and completing the surveys
Adherence as Measured by the Percentage of Contributed Data Over the Course of the Study3 months of wearing the Fitbit and completing the surveysContributed data percentages are shown by caregiver group (HD, SCI, HCT) for daily surveys, daily steps, daily sleep, calculated by number of days of data provided divided by number of total possible days that it could be provided.

Countries

United States

Participant flow

Participants by arm

ArmCount
Control
Participants wore the Fitbit® and provided daily reports of health related quality of life (HRQOL) over a three-month (90 day) period (without the personalized feedback).
34
Just-in-time Adaptive Intervention (JITAI)
Participants wore the Fitbit®, provided daily reports of health related quality of life (HRQOL) and received personalized pushes over a three-month (90 day) period. Just-in-time adaptive intervention (JITAI): JITAI is an emerging intervention that incorporates passive mobile sensor data feedback (sleep and activity \[step\] data from a Fitbit ®), and real-time self-reporting of HRQOL via a study specific app called CareQOL to provide personalized feedback via app alert.
36
Total70

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyIneligible after medical record review; documentation for SCI not sufficient20
Overall StudyLost to Follow-up10

Baseline characteristics

CharacteristicControlJust-in-time Adaptive Intervention (JITAI)Total
Age, Continuous56.1 years
STANDARD_DEVIATION 14.5
54.4 years
STANDARD_DEVIATION 13.1
55.2 years
STANDARD_DEVIATION 13.7
Caregiver group
Hematopoietic cell transplantation (HCT)
15 Participants15 Participants30 Participants
Caregiver group
Huntington Disease (HD)
10 Participants11 Participants21 Participants
Caregiver group
Spinal Cord Injury (SCI)
9 Participants10 Participants19 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants2 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
34 Participants33 Participants67 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants3 Participants3 Participants
Race (NIH/OMB)
Black or African American
1 Participants1 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants3 Participants3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
33 Participants29 Participants62 Participants
Region of Enrollment
United States
34 Participants36 Participants70 Participants
Sex/Gender, Customized
Do not wish to report
1 Participants0 Participants1 Participants
Sex/Gender, Customized
Female
21 Participants28 Participants49 Participants
Sex/Gender, Customized
Male
12 Participants8 Participants20 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 340 / 36
other
Total, other adverse events
1 / 342 / 36
serious
Total, serious adverse events
0 / 340 / 36

Outcome results

Primary

Feasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility Questionnaire

Items are scaled from 1 to 5 to indicate the level of agreement, where 1 indicates strong disagreement and 5 indicates strong agreement. Percentages shown are the combined percentage of participants who selected agree or strongly agree or their equivalent (as labeled).

Time frame: 3 months of wearing the Fitbit and completing the surveys

Population: one participant did not complete this measure

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireInstructions for the Fitbit®️ were easy to understand.62 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireThe Fitbit® was easy to set up.63 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireThe Fitbit® was easy to use.64 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireThe Fitbit® was comfortable to wear.60 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireThe Fitbit® was easy to sync with my phone.58 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireI was confident using the Fitbit®59 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireThe instructions for the CareQOL app set up were easy to understand.66 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireThe CareQOL app was easy to set up.65 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireThe CareQOL app was easy to use.67 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireI was confident using the CareQOL app67 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireI am confident that I was using the CareQOL app correctly.65 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireThe daily questions on the app were easy to understand.65 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireThe daily questions on the app were easy to answer.62 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireAnswering the daily questions fit easily into my routine.62 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireThe number of daily questions to answer on the app was reasonable.69 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireThe monthly surveys on the app were easy to understand.66 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireThe monthly surveys on the app were easy to answer.63 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireAnswering the monthly surveys fit easily into my routine.65 Participants
All Participants, in a Whole SampleFeasibility and Acceptability as Measured by the Percentage of Agree or Strongly Agree Responses to the Individual Items on the Feasibility QuestionnaireThe number of questions in the monthly surveys was reasonable.63 Participants
Secondary

Adherence as Measured by the Percentage of Contributed Data Over the Course of the Study

Contributed data percentages are shown by caregiver group (HD, SCI, HCT) for daily surveys, daily steps, daily sleep, calculated by number of days of data provided divided by number of total possible days that it could be provided.

Time frame: 3 months of wearing the Fitbit and completing the surveys

Population: Data are presented separately by caregiver group to inform future caregiver studies that may elect to focus on a single caregiver group, as opposed to caregivers more generally.

ArmMeasureGroupValue (MEAN)Dispersion
All Participants, in a Whole SampleAdherence as Measured by the Percentage of Contributed Data Over the Course of the StudyDaily Sleep82 percentage of dataStandard Deviation 29
All Participants, in a Whole SampleAdherence as Measured by the Percentage of Contributed Data Over the Course of the StudyDaily survey90 percentage of dataStandard Deviation 12
All Participants, in a Whole SampleAdherence as Measured by the Percentage of Contributed Data Over the Course of the StudyDaily Steps98 percentage of dataStandard Deviation 2
SCI Care PartnersAdherence as Measured by the Percentage of Contributed Data Over the Course of the StudyDaily Sleep80 percentage of dataStandard Deviation 27
SCI Care PartnersAdherence as Measured by the Percentage of Contributed Data Over the Course of the StudyDaily survey84 percentage of dataStandard Deviation 14
SCI Care PartnersAdherence as Measured by the Percentage of Contributed Data Over the Course of the StudyDaily Steps90 percentage of dataStandard Deviation 18
HCT Care PartnersAdherence as Measured by the Percentage of Contributed Data Over the Course of the StudyDaily Sleep90 percentage of dataStandard Deviation 21
HCT Care PartnersAdherence as Measured by the Percentage of Contributed Data Over the Course of the StudyDaily survey92 percentage of dataStandard Deviation 8
HCT Care PartnersAdherence as Measured by the Percentage of Contributed Data Over the Course of the StudyDaily Steps99 percentage of dataStandard Deviation 2
Secondary

Attrition as Measured by the Percent of Participants Completing the Study

Time frame: 3 months of wearing the Fitbit and completing the surveys

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
All Participants, in a Whole SampleAttrition as Measured by the Percent of Participants Completing the Study69 Participants

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026